In October 2022 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Kenyan Athlete Ibrahim Mukunga Wachira after his sample tested positive for the prohibited substances 19-norandrosterone (Nandrolone) and Tamoxifen.
Following notification a provisional suspension was ordered and the Athlete filed a statement in his defence. He explained with evidence that he underwent medical treatment in a clinic in Kenya for his knee injury and that Nandrolone injections had been administered.
The AIU had requested assistance from the Anti-Doping Agency of Kenya (ADAK) to investigate the Athlete's explanations. Hereafter ADAK's investigations confirmed that the Athlete underwent treatment in this clinic.
In May 2024 the AIU charged the Athlete with an anti-doping rule violation and thereupon the he failed to respond. The AIU determines that the his medical treatment could not explain the presence of Tamoxifen in his sample and that there are aggravating circumstances present in this case.
Because the Athlete did not respond within the set deadline the AIU determines in June 2024 that the Athlete was deemed to have waived his right for a hearing and accepted the consequences. In addition the AIU establishes that he had had failed to sign and submit the Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form.
Therefore the AIU decides on 17 June 2024 to impose a 6 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 4 October 2022.
